[1]
G. . Rakshit and V. Jayaprakash, “#51 Design, development, and evaluation of pyrazoline based mycobactin analogues as anti-tubercular agents: An in-silico approach”, J Pharm Chem, vol. 8, no. Supplement, Jul. 2022, Accessed: Apr. 29, 2024. [Online]. Available: https://pubs.vensel.org/index.php/jphchem/article/view/170